Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 40

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 virus H5N1 pandemic assay vaccine H1N1 a(h1n1)pdm09 H7N9 antiviral lung markets bats swine IDV °
2 influenza poultry influenza detection protection 2009 - mabs oseltamivir cells live H9N2 pigs IBV airway
3 viruses spread global specimens vaccines swine sequences neutralizing resistance epithelial aivs ducks dogs HA BST-2
4 human avian pandemics detect challenge pneumonia season monoclonal inhibitors H5N1 poultry bat H1N2 IAV family
5 avian H5 health RT-PCR vaccination % NA antibodies drugs alveolar lbms duck sivs fusion winter
6 infection highly influenza pandemic sensitivity H5N1 mexico A(H3N2 H7 neuraminidase cytokine A(H7N9 H9 days entry temperature
7 influenza viruses pathogenic vaccines rrt-pcr recombinant pandemic mutation HA drug msc-evs market chickens nasal influenza c virus orthomyxoviridae
8 influenza virus birds influenza pandemics reaction inactivated ph1n1 analysis h7n9 virus treatment cytokines prevalence MDCK avian-like HEF organoids
9 viral asia flu influenza responses 84 mutations epitopes neuraminidase inhibitors macrophages risk bat-influenza pig kallistatin shift
10 respiratory AIV strategies real-time mice test phylogenetic 2013 agents h5n1 virus conducted chicken nomenclature activation temperatures
11 results HPAI emerging assays antigenic individuals substitution h7n9 viruses amantadine primary practices ecology avian‐like protease flies
12 host domestic recent rapid survival influenza-like orvs ELISA antivirals mdms LBM H17N10 inoculated KLK1 antigenic shift
13 high humans preparedness sensitive lethal states PB1–216 neutralization children h1n1 virus 's H18N11 H3N2 ph orthomyxoviridae family
14 humans 1997 strategy H275Y cross-protection herds evolution mab treat chemokines collected h9n2 viruses controls membrane fusion types
15 potential h5n1 viruses concern multiplex heterologous h1n1 infection taiwan stem channel MBL environmental mdck cells sw/gent/08 stability persistence
16 suggest H2 pandemic influenza clinical DNA hospital japan monoclonal antibodies activity h5n1 disease trading modified thai cattle differentiated
17 infected subtypes future samples proteins bacterial co-infection conserved therapy autophagy LPT PB1-F2 H1 TBHQ orthomyxoviruses
18 influenza a virus epidemiology years specific peptide influenza-like illness egypt epitope seasonal influenza H9N2/G1 live bird HP diversity glycoprotein environmental conditions
19 strains mortality remains developed induced swine flu isolates binding stage pathogenesis network acid revealed proteases human-infective
20 tract countries research clinical specimens NP CRP neuraminidase 8C6 M2 in vitro flocks DV518 inoculation proteolytic sore throat
21 caused asian public RNA protected 17 waves region patients vitro surveillance dromedary avian‐like swine loop sore
22 low domestic poultry current A/H1N1 protective united states A/H1N1 river ± H5N1/97 bird jinchai introductions structural conditions
23 study 2003 response PCR vectors mixed clustered avian-origin D35 inflammatory workers dromedary camels H1N1/2009 erythrocytes ciliated
24 infections infectious international positive m2e circulated infecting neutralizing antibody NA potent rural amino titers cleavage 32
25 ability populations epidemic swl immune swine influenza influenza a(h3n2 pseudovirus NAI induction wild birds cells reassortant attractive quasispecies
26 virulence transmission work chain igg investigations seasons h7n9 infections zanamivir proinflammatory odds SA guinea inhibits family orthomyxoviridae
27 isolated pathogenic avian influenza studies % antibody swine influenza h1n1 pneumonia strains group rimantadine virus-induced cloacal h9n2 virus excretion membrane single-stranded
28 significant zoonotic development primers t-cell ridts phylogenetic analysis ha protein adamantanes IP-10 kenya acids sublineage influenza d virus rna segments
29 respiratory tract large threat probes hetero-protection ilis sequence IAV ion cell free-grazing camels seropositivity 32D6 single-stranded rna
30 identified wild national reverse wild-type PCT selection delta prophylaxis induced live bird markets p518-l nasal virus quercetin infective
31 studies infections timely screening M2 epitope LPAI belonging drug resistance replicated LPM bat cells belonged conformation type c
32 ferrets viruses killed performance influenza vaccine cases 2 therapeutic proton pdmh1n1 wild passages 3 pseudotyped ivs
33 causing economic critical detecting clades adults online china young PVA year intestinal antibodies TMPRSS2 influenza illness
34 previously control led a/h1n1v HPAI patients viral interference h7n9 influenza μg/ml alveolar epithelial cells spatial bat species 1 matriptase/st ISAV
35 genetic mortality rate production a/h1n1pdm antigens ph1n1 virus supplementary ten drug-resistant evs backyard IFITM1 h1n1pdm09 bativs RNA
36 reduced including system 2009 protect producing authorized PN-SIA28 therapies polarized farmers acquired domestic ducks infectivity airways
37 transmitted species plans commercial hemagglutinin mexico city SUPPLEMENTARY MN compound pathways environmental samples tracheas web-accessible determinant transmission
38 pathogenic east recommendations negative HA clones signatures reacted infants apical movement bat-influenza virus dog permeability fever
39 pandemic emergence care analytical encoding pandemic influenza a monitor monoclonal antibody seasonal apoptosis contacts species danish CPIV environmental
40 unique 2.3.4.4 < one-step immunization clinical users vlps-tm regimen expression H4N9 role intranasally myxoviruses productive
41 transmission influenza a viruses bird RT‐PCR immunized flu phylogeography sandwich TCAD lung epithelial cells H7N4 p518-s comparisons anti-iav h7n9/ah
42 influenza virus infection subtype h5n1 avian influenza seasonal m2e-map variant gene PN febrile basolateral urban α2,6-gal equine proteolytic cleavage h1n1sw
43 tissue difficult controlling gene TM non-seasonal PB1–216S pseudotypes avian flu chemokine risk factors primates cross‐protection kallikrein adar1-like
44 demonstrate terms pandemic influenza vaccines pandemic influenza a/h1n1 immune responses make tree specific shikimic mscs birds madin-darby canine kidney contemporary ICV headache
45 syndrome H2N2 manufacturing clinical samples effective procalcitonin al blot OS inducers samples explain virus titers utilizes droplets
46 persons potential (0)(F H1N1 h5n1 virus 39 influenza a/h1n1 viruses a/anhui/1/2013 clinical features H5N1/04 chickens DV413 household stabilizing tilv
47 subtypes human emergence influenza a h1n1 weight loss division inhibition assay subunits viral organ patient ns1 protein wash low-ph house
48 disease transmissible correlates rtrt-pcr vector originating ELECTRONIC coverage severe dysregulation 2013 bat influenza viruses arose enzymes 3D
49 vivo routes spreading procedures LAIV thought MATERIAL rhmbl suppressed microvascular circulation ch9cn2/h18 genetic viral spread 2D
50 objective south-east asia mathematical RT-LAMP sh5(3 reverse transcription polymerase chain reaction HA anti-hemagglutinin AD3BF2D signalling % ch9cn2/h17 genes bativ aerosols